Development of a Population-Based Cancer Case-Control Study in Southern China
Weimin Ye,Ellen T Chang,Zhiwei Liu,Qing Liu,Yonglin Cai,Zhe Zhang,Guomin Chen,Qi-Hong Huang,Shang-Hang Xie,Su-Mei Cao,Jian-Yong Shao,Wei-Hua Jia,Yuming Zheng,Jian Liao,Yufeng Chen,Longde Lin,Liming Liang,Ingemar Ernberg,Thomas L Vaughan,Guangwu Huang,Yi Zeng,Yi-Xin Zeng,Hans-Olov Adami
DOI: https://doi.org/10.18632/oncotarget.19692
2017-01-01
Oncotarget
Abstract:With its population of over 1.3 billion persons, China offers abundant opportunities to discover causes of disease. However, few rigorous population-based case-control studies have as yet been conducted in mainland China. We conducted a population-based case-control study of nasopharyngeal carcinoma in Guangdong Province and Guangxi Autonomous Region. We collected questionnaires and biospecimens from incident cases recruited between March 2010 and December 2013, and population-based controls between November 2010 and November 2014. Preparatory activities prior to subject enrollment required approximately 18 months. We enrolled a total of 2554 NPC cases and 2648 controls. Among all identified cases, 83.8% participated. For the participating cases, the median time between diagnosis and interview was 2 days. Among all contacted controls, 82.7% participated. From the enrolled cases, we collected 2518 blood specimens (provided by 98.6% of eligible cases), 2350 saliva specimens (92.0%), 2514 hair specimens (98.4%), and 2507 toenail/fingernail specimens (98.2%). From the enrolled controls, we collected 2416 blood specimens (91.2%), 2505 saliva specimens (94.6%), 2517 hair specimens (95.1%), and 2514 toenail/fingernail specimens (94.9%). We demonstrate that population-based epidemiologic research can successfully be conducted in southern China. The study protocols, databases, and biobank will serve as an extraordinarily valuable resource for testing future etiologic hypotheses.